Interaction between clopidogrel and PPIs

The EU Committee for Medicinal Products for Human Use (CHMP) has stated that the concomitant use of a proton pump inhibitor (PPI) with clopidogrel is not recommended unless considered essential.

Following several recently published studies, the CHMP concluded that a clinically significant interaction exists between clopidogrel and PPIs. The studies examined the clinical outcomes of patients taking clopidogrel and suggested that a significant interaction occurs between clopidogrel and PPIs, making clopidogrel less effective.

This interaction has important implications. PPIs are often prescribed concomitantly to offer gastroprotection as clopidogrel is associated with gastrointestinal symptoms.

The CHMP advice for healthcare professionals is that all patients currently receiving the two drugs should be reviewed at their next appointment; PPIs should only be prescribed strictly within their licensed indications and that prescribers should check that patients prescribed clopidogrel are not buying over-the-counter omeprazole.

Further information: European Medicines Agency Public statement

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases